Infinity stock dips as it stops development of lung cancer drug
September 25, 2013 at 13:35 PM EDT
Stock in Infinity Pharmaceuticals Inc. (Nasdaq: INFI) dipped 4 percent Wednesday as the company said a mid-stage trial of a potential lung cancer drug did not do significantly better than a placebo...
